Diabetes is a condition that impacts over 3 million Canadians. That is approximately 8.8% of the population, further, it is estimated that 6.1% of the Canadian adult population are at high risk of developing diabetes.
The CanTreatCOVID is unique in that it’s an adaptive platform trial, which will allow it to compare multiple treatments simultaneously, in real-world conditions.